Nuclear Medicine: Page 281

Dilon touts study on BSGI costs

By AuntMinnie.com staff writers

Scintimammography developer Dilon Technologies is touting results of a study that concludes that breast-specific gamma imaging (BSGI) is substantially less expensive than MRI.

October 11, 2009

ABT nets $9M in financing

By AuntMinnie.com staff writers

ABT Molecular Imaging has secured a $9 million round of financing.

October 8, 2009

AECL moves toward NRU repairs

By AuntMinnie.com staff writers

Atomic Energy of Canada (AECL) this week completed data analysis that confirms that only six locations within its National Research Universal (NRU) nuclear reactor at Chalk River, Ontario, are in need of repair.

October 8, 2009

Bayer, AC Immune join forces

By AuntMinnie.com staff writers

German pharmaceutical firm Bayer Schering Pharma is providing its florbetaben PET tracer to Swiss biopharmaceutical company AC Immune for an Alzheimer's disease clinical trial.

October 8, 2009

FDG-PET uptake helps predict vascular events in cancer patients

By Wayne Forrest

German researchers have discovered that FDG uptake in major arteries is the "strongest predictor of a subsequent vascular event" in cancer patients, with severe calcification also indicating high risk, according to an article published in the October issue of the Journal of Nuclear Medicine.

October 8, 2009

Philips develops silicon photomultiplier technology

By AuntMinnie.com staff writers

Philips Healthcare parent Royal Philips Electronics said it has developed a digital silicon photomultiplier technology that it believes will allow for faster and more accurate photon counting in applications such as PET imaging.

October 7, 2009